Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex molecules. Improving these processes involves adjusting various parameters, including cell line selection, media composition, and bioreactor conditions. A key goal is to maximize antibody titer while minimizing production expens